These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1277192)

  • 1. The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system.
    Gordon MY; Blackett N
    Cancer Res; 1976 Aug; 36(8):2822-6. PubMed ID: 1277192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Marsh JC
    Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy.
    Slørdal L; Warren DJ; Moore MA
    Cancer Res; 1990 Jul; 50(14):4216-20. PubMed ID: 2364379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
    Selby PJ; Steel GG
    Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells.
    Marsh JC
    Cancer Treat Rep; 1982 Mar; 66(3):499-504. PubMed ID: 6460555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The toxic action of antineoplastic chemotherapeutic agents evaluated by study of hemopoietic stem cells].
    Pannacciulli I; Ghio R; Bianchi G; Bogliolo G; Saviane A; Massa G
    Minerva Med; 1978 Dec; 69(61):4257-65. PubMed ID: 366466
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
    Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term consequences of chemotherapeutic agents on hematopoiesis: development of altered radiation tolerance.
    Kovacs CJ; Evans MJ; Hooker JL; Johnke RM
    NCI Monogr; 1988; (6):45-9. PubMed ID: 3352788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells.
    Ogawa M; Gale GR; Keirn SS
    Cancer Res; 1975 Jun; 35(6):1398-401. PubMed ID: 1131815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of cytotoxic drugs for residual bone marrow damage.
    Trainor KJ; Morley AA
    J Natl Cancer Inst; 1976 Dec; 57(6):1237-9. PubMed ID: 1003558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effect of cytotoxic agents on agar colony forming cells, spleen colony forming cells, and the erythrocytic repopulating ability of mouse bone marrow.
    Millard RE; Blackett NM; Okell SF
    J Cell Physiol; 1973 Oct; 82(2):309-17. PubMed ID: 4753424
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral stimulation of hemopoietic progenitors from human fetal liver.
    Niskanen E; Champlin R; Oki A; Golde DW; Gale RP; Cline MJ
    Stem Cells (1981); 1982; 2(4):246-52. PubMed ID: 6132450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
    Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
    Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.